Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort

BACKGROUND: With regard to switching tumor necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA), conflicting results have been reported as to whether the effectiveness of a second TNFi depends on the reason for discontinuation of the first TNFi. METHODS: Patients with a clinical diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciurea, Adrian, Exer, Pascale, Weber, Ulrich, Tamborrini, Giorgio, Steininger, Beate, Kissling, Rudolf O., Bernhard, Jürg, Scherer, Almut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802885/
https://www.ncbi.nlm.nih.gov/pubmed/27000865
http://dx.doi.org/10.1186/s13075-016-0969-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802885/
https://www.ncbi.nlm.nih.gov/pubmed/27000865
http://dx.doi.org/10.1186/s13075-016-0969-2

Ejemplares similares